GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)Stock · Health Care$50.22-1.65%
as of market close, Sep 18, 2026
☾ AH — —
GSK — GSK plc American Depositary Shares (Each representing two Ordinary Shares) price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD
30.035.040.045.050.055.060.0050.0M$50.22—20162019202120242026
2026-09-18
Price$50.22
MA20$52.11
MA50$49.23
Vol13.4M
Key stats
Price data
- Price
- $50.22
- Change YTD
- +2.41%
- Next earnings
- Nov 4, 2026
- Market cap
- 103.4B
- Enterprise value
- 122.7B
- Shares outstanding
- 2.1B
- 52W low
- $39.29
- 52W high
- $61.70
- From 52W high
- -18.61%
- From 52W low
- +27.82%
- 52W range
- 49%
- Beta
- 0.38
Volume
- Rel volume
- 1.61×
- 30D volume
- 2.9M
- 30D $ vol
- 147.6M
Fundamentals
- Sales (ttm)
- 43.1B
- Sales/share
- $20.95
- EPS (ttm)
- $3.66
- FCF (ttm)
- 10.2B
- FCF/share
- $4.96
- Book value/share
- $10.71
- Net margin
- 19.25%
- ROE
- 37.65%
- ROA
- 10.09%
- Debt / equity
- 0.90×
- Current ratio
- 0.82
Growth (CAGR, ttm) · 10Y
- Sales
- +7.57%+6.06%+6.66%+1.66%
- Net income
- +120.30%-24.45%+0.26%-4.24%
- Shares
- -0.60%+0.27%+0.43%-1.70%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +130.68%-25.95%+0.03%-3.56%
- Sales/share
- +8.23%+5.77%+6.21%+3.42%
- Book value/share
- +29.03%+19.62%+1.85%+7.12%
- Dividend/share
- +11.79%+4.89%-7.45%-3.33%
- Price
- +24.63%+10.37%+5.22%+1.59%
- Total return
- +29.05%+14.75%+9.56%+6.45%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 13.7×
- P/OI (ttm)
- 9.9×
- Fwd P/E
- 10.1×
- P/S (ttm)
- 2.4×
- P/B (mrq)
- 4.7×
- P/FCF (ttm)
- 10.1×
- EV/EBITDA (fy)
- 9.1×
- EV/Sales (ttm)
- 2.8×
- FCF yield (ttm)
- 9.89%
- Dividend yield (fwd)
- 3.47%
- Dividend/share (fwd)
- $1.74
- Buyback yield (cash, ttm)
- 1.74%
- Shareholder yield (cash, ttm)
- 5.01%
Vs own 10Y history
- P/E
- 35th
- P/OI
- 21st
- P/S
- 47th
- P/B
- 32nd
Bar = where today’s multiple sits in GSK’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-09-18
1D
-1.65%
5D
+4.34%
1M
-1.82%
3M
-0.89%
YTD
+2.41%
1Y
+24.62%
5Y
+29.00%
Financial statements
Open full GSK financials →Loading financial statements…
Related Health Care
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| NVS | Novartis AG | -9.18% | -0.39% |
| NVO | Novo Nordisk A/S | -5.40% | +0.12% |
| SNY | Sanofi ADS | -5.54% | -1.53% |
| ARGX | argenx SE American Depositary Shares | -0.27% | -0.55% |
| TAK | Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | +4.76% | -0.73% |
| NTRA | Natera Inc. | +18.51% | +0.84% |
| TEVA | Teva Pharmaceutical Industries Limited American Depositary Shares | +6.56% | -0.54% |
| RVMD | Revolution Medicines Inc. | -11.60% | -3.04% |
GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) trades at $50.22 with a live price and an interactive chart covering 46+ years of daily price history, plus key valuation metrics. ChartRow also publishes GSK’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full GSK financial statements →
